GBX2 Methylation Is a Novel Prognostic Biomarker and Improves Prediction of Biochemical Recurrence Among Patients with Prostate Cancer Negative for Intraductal Carcinoma and Cribriform Architecture
Titel:
GBX2 Methylation Is a Novel Prognostic Biomarker and Improves Prediction of Biochemical Recurrence Among Patients with Prostate Cancer Negative for Intraductal Carcinoma and Cribriform Architecture
Auteur:
Jeyapala, Renu Savio, Andrea J. Olkhov-Mitsel, Ekaterina Kamdar, Shivani Zhao, Fang Cuizon, Carmelle Liu, Richard S.C. Zlotta, Alex Fleshner, Neil van der Kwast, Theodorus Bapat, Bharati